Literature DB >> 25651220

Myelopathy associated with microorganisms.

Jennifer L Lyons.   

Abstract

PURPOSE OF REVIEW: This article reviews the common infectious etiologies of spinal cord dysfunction that span the globe epidemiologically and vary pathophysiologically. RECENT
FINDINGS: Many microorganisms have the ability to directly or indirectly result in spinal cord dysfunction. These agents may have the ability to infect the spinal cord itself, but frequently cause indirect damage by parainfectious or postinfectious immune-mediated destruction or external compression of the spinal cord.
SUMMARY: Infectious myelopathies can pose diagnostic difficulty but are potentially reversible causes of spinal cord dysfunction. The often complex relationship among the infectious agent, the immune system, and the neuraxis can create a difficult management conundrum whereby immune modulation may be the preferred approach.

Entities:  

Mesh:

Year:  2015        PMID: 25651220     DOI: 10.1212/01.CON.0000461087.56371.e8

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  3 in total

1.  Etiological profile of noncompressive myelopathies in a tertiary care hospital of Northeast India.

Authors:  Ashok Kumar Kayal; Munindra Goswami; Marami Das; Lakhshya Jyoti Basumatary; Suvorit Subhas Bhowmick; Baiakmenlang Synmon
Journal:  Ann Indian Acad Neurol       Date:  2017 Jan-Mar       Impact factor: 1.383

2.  Acute transverse myelitis in West Nile Virus, a rare neurological presentation.

Authors:  Chinmay Jani; Alexander Walker; Omar Al Omari; Dipesh Patel; Alejandro Heffess; Edward Wolpow; Stephanie Page; Daniel Bourque
Journal:  IDCases       Date:  2021-03-31

3.  Acute myelitis and SARS-CoV-2 infection. A new etiology of myelitis?

Authors:  Daniel Águila-Gordo; José Manuel Flores-Barragán; Ferran Ferragut-Lloret; Jaime Portela-Gutierrez; Beatriz LaRosa-Salas; Lourdes Porras-Leal; José Carlos Villa Guzmán
Journal:  J Clin Neurosci       Date:  2020-09-30       Impact factor: 1.961

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.